<DOC>
	<DOC>NCT00310752</DOC>
	<brief_summary>The primary purpose of this study is to evaluate the safety of DermaStream(tm) in the management of chronic wounds. Other goals of this study are to gain feedback from patients and healthcare providers on the ease of use (the ergonomic aspect) of the device, and to make a preliminary evaluation of the efficacy of DermaStream(tm) in chronic wound management.</brief_summary>
	<brief_title>Evaluation of DermStream(tm) - an Irrigation Product for Chronic Wound Management</brief_title>
	<detailed_description>Until now no expected or unexpected adverse events were occurred</detailed_description>
	<mesh_term>Venous Insufficiency</mesh_term>
	<criteria>Diabetic ulcer, OR Venous insufficiency ulcer Age range: 1880 years Wound max. diameter range: 1.5 10 centimeters Wound San Antonio assessment system: grade 1 and 2, stage A and B Palpable pulses in the Posterior Tibial and the Dorsalis Pedis arteries AnkleBrachial Index &gt; 0.7 by Doppler Wound present for at least 6 weeks Wound location: foot or calf, at a location where the device can be attached properly Lack of purulent discharge from the wound. Hypoalbuminemia: Albumin &lt; 2gr/dl Rightside congestive heart failure with edema of legs: +2 or higher Renal insufficiency: Cr &gt; 2 mg/dl Abnormal liver function: ALT or AST&gt;300 Skin disorders adjacent to the wound, unrelated to the pathology of the wound Noncooperative patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>